Clinical Trial Update: Lurasidone Pediatric Pharmacokinetics Study [Phase 1]

View source ↗

Summary

Phase 1 pediatric pharmacokinetics study of lurasidone in children with schizophrenia or autism has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Schizophrenia

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Autism | Phase 1 | Status: COMPLETED | Results posted: 2014-07-31